PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease

Neurotherapeutics - United States
doi 10.1016/j.nurt.2008.05.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapeutics of Neurotransmitters in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2017English

PPAR Agonists: Potential as Therapeutics for Neovascular Retinopathies

PPAR Research
Drug DiscoveryPharmacology
2008English

Are Biomarkers Valid as Surrogates for Treatment Effects in Alzheimer’s Disease?

European Neurological Review
Neurology
2009English

Identification of Tetrahydrocarbazoles as Novel Multifactorial Drug Candidates for Treatment of Alzheimer’s Disease

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2014English

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease

Marine Drugs
Drug Discovery
2019English

Anti-Hmgb1 Antibodies and Alpha-7 Agonists as Experimental Therapeutics as BW Countermeasures

2006English

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2019English

Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer’s Disease

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer’s Disease

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy